Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1128|35|3|586-618

ISSN： 0198-6325

Source： MEDICINAL RESEARCH REVIEWS, Vol.35, Iss.3, 2015-05, pp. : 586-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Human C‐Type Lectin‐like Molecule‐1 (CLL1) with a Bispecific Antibody for Immunotherapy of Acute Myeloid Leukemia

By  

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 53, Iss. 37, 2014-09 ,pp. : 9841-9845

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting Human C‐Type Lectin‐like Molecule‐1 (CLL1) with a Bispecific Antibody for Immunotherapy of Acute Myeloid Leukemia

By  

ANGEWANDTE CHEMIE, Vol. 126, Iss. 37, 2014-09 ,pp. : 9999-10003

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selective Inhibitors of Glutathione Transferase P1 with Trioxane Structure as Anticancer Agents

By  

CHEMMEDCHEM, Vol. 10, Iss. 4, 2015-04 ,pp. : 629-639

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibitors of Molecular Chaperones as Therapeutic Agents. Edited by Timothy D. Machajewski and Zhenhai Gao

By  

CHEMMEDCHEM, Vol. 10, Iss. 3, 2015-03 ,pp. : 581-582

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic Targets for Inhibitors of Glycosylation

By Alonzi Dominic S.  

CHIMIA International Journal for Chemistry, Vol. 65, Iss. 1, 2011-02 ,pp. : 35-39

Swiss Chemical Society

Access to resources Recommend Favorite